|
|
|
|
|
|
 |
First independent installation of IMMULITE 2000 XPi at Yorkshire ClinicFirst independent installation of IMMULITE 2000 XPi at Yorkshire Clinic
Reliability and efficiency gains for immunoassay testing
The Yorkshire Clinic, part of the Ramsay Health Care group, has recently upgraded its immunoassay system to an IMMULITE® 2000 XPi from Siemens Healthcare Diagnostics. This is the first placement of this analyser into an independent healthcare provider and one of the first placements in the UK. It will assist with the rapid turnaround of thyroid, haematinics, gonadotrophins and tumour marker testing.
The features of the IMMULITE 2000 XPi have enabled the hospital to reduce the time it takes to obtain quick and accurate test results. This has aided the long-term strategy of the Ramsay Health Care group which is to develop the Yorkshire Clinic as its in-house centre for immunoassay testing. |
 |
Improved patient profiling with Randox Metabolic Syndrome ArraysImproved patient profiling with Randox Metabolic Syndrome Arrays
The Metabolic Syndrome Arrays from Randox offer simultaneous determination of analytes associated with Metabolic Syndrome and related disorders for improved patient profiling.
These arrays are of the highest quality and offer excellent performance, ensuring you receive results you can trust. |
 |
Myconostica Announces CE Marking of MycAssay™ Product Family on Additional PlatformsMyconostica Announces CE Marking of MycAssay™ Product Family on Additional Platforms
Manchester, United Kingdom, August 9, 2010 / b3c newswire / - Myconostica Ltd, the UK-based medical diagnostic company developing and commercialising rapid and highly specific tests for life-threatening fungal infections, today announces the CE marking of its lead products MycAssay™ Aspergillus and MycAssay™ Pneumocystis on the Roche Lightcycler® 2.0 and Stratagene Mx3000 series platforms. |
 |
Lab M and bioTRADING celebrate business successLab M and bioTRADING celebrate business success
9 August 2010; Bury, UK: Microbiology specialist Lab M is celebrating the anniversary of another enduring partnership, demonstrating the company’s ability to nurture the long term relationships crucial to the success of an international business. It is now 28 years since Lab M entered into a distribution partnership with bioTRADING Benelux B.V., based in Mijdrecht in The Netherlands. This strong partnership continues to ensure the efficient delivery of Lab M microbiological culture media to laboratories throughout The Netherlands and Luxembourg. |
 |
BBI Investment Extends Marketing ExcellenceBBI Investment Extends Marketing Excellence
BBInternational strengthens its marketing team with the addition of a new Diagnostics Marketing Manager into the team.
Dr Nanette Bartram has joined the BBI Diagnostics division and brings a wealth of experience of working in both diagnostic and life science companies such as Invitrogen, Dynal Biotech, and Bio-Rad Laboratories in a number of roles including marketing, field sales, business development and product management. |
|
Accurately and efficiently monitor the performance of HbA1c assaysAccurately and efficiently monitor the performance of HbA1c assays
The American Diabetes Association, International Diabetes Federation and European Association for the Study of Diabetes consider HbA1c a more reliable indicator of long term diabetic control than blood glucose. |
|
Automated laboratory solution is catalyst for Lean changeAutomated laboratory solution is catalyst for Lean change
Time savings gained at Leicester Royal Infirmary from sample processing efficiencies
A review of specimen reception and preliminary sample handling using ‘Lean’ principles has led to improvements in the processing of a daily workload of 11,000 samples at the Leicester Royal Infirmary (LRI) Pathology Department. The sample process step that used to take 4 hours 30 minutes has been reduced to 20 minutes and a previous build up of up to 1000 samples at any given time has been eliminated. What used to be a difficult-to-manage ‘push’ workflow is now an organised and simple ‘pull’ workflow. |
|
Highly specific monoclonal antibodies available from Randox Life SciencesCrumlin, UK, 27th July 2010
Highly specific monoclonal antibodies available from Randox Life Sciences
Randox Life Sciences is a recognised primary manufacturer of high quality, cost effective monoclonal antibodies to both classic and novel targets.
The complete product range is manufactured at our state of the art facilities in the United Kingdom and are certified to the highest quality standards including ISO13485: 2003, UKAS ILAC G-13:2007 and ISO17025. |
|
Myconostica announces successful continuation of D round with investment by Medac Myconostica announces successful continuation of D round with investment by Medac
19 July 2010
Myconostica Ltd, the UK-based medical diagnostic company developing and commercialising rapid and highly specific tests for life-threatening fungal infections, today announces the completion of an investment by medac Gesellschaft fuer klinische Spezialpraeparate mbH. |
 |
Abbott Receives European Regulatory Approval for New Ovarian Cancer Diagnostic TestAbbott Receives European Regulatory Approval for New Ovarian Cancer Diagnostic Test
Abbott announces CE Mark (Conformité Européene) certification for the ARCHITECT human epididymis protein 4 (HE4) test
Maidenhead, UK, June 16, 2010 — A new diagnostic tool, which studies show can aid in determining the risk of whether a pelvic mass is benign or malignant, is now available in Europe. This simple blood test is expected to help in the assessment of epithelial ovarian cancer, the most lethal form of gynecological cancer. This important immunoassay, which will run on Abbott’s ARCHITECT systems, is the first automated HE4 test.
|
|
|
|
|
|
|
|
|
|
|
|